Tempus AI, Inc.TEMEarnings & Financial Report
Tempus AI, Inc. is an American health technology company founded in 2015 by Eric Lefkofsky in Chicago, Illinois. It was established by Lefkofsky soon after his wife was diagnosed with breast cancer. Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, for oncology, cardiology, radiology, and depression. The company went public on the Nasdaq on June 14, 2024, under the ticker symbol "TEM."
Revenue
$314.6M
Gross Profit
N/A
Operating Profit
$-61.8M
Net Profit
$-42.8M
Gross Margin
N/A
Operating Margin
-19.6%
Net Margin
-13.6%
YoY Growth
89.6%
EPS
$-0.25
Financial Flow
Tempus AI, Inc. Q2 2025 Financial Summary
Tempus AI, Inc. reported revenue of $314.6M (up 89.6% YoY) for Q2 2025, with a net profit of $-42.8M (up 92.2% YoY) (-13.6% margin). Cost of goods sold was N/A.
Key Financial Metrics
| Total Revenue | $314.6M |
|---|---|
| Net Profit | $-42.8M |
| Gross Margin | N/A |
| Operating Margin | -19.6% |
| Report Period | Q2 2025 |
Revenue Breakdown
Tempus AI, Inc. Q2 2025 revenue of $314.6M breaks down across 3 segments, led by Genomics Product at $241.8M (76.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Genomics Product | $241.8M | 76.9% |
| Insights Product | $57.2M | 18.2% |
| Related Party | $15.9M | 5.1% |
Tempus AI, Inc. Revenue by Segment — Quarterly Trend
Tempus AI, Inc. revenue by segment across the last 4 reported quarters, showing how each business line (such as Genomics Product and Insights Product) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Genomics Product | — | $252.9M | $241.8M | $193.8M |
| Insights Product | — | $69.0M | $57.2M | $49.5M |
| Related Party | — | — | $15.9M | — |
Tempus AI, Inc. Annual Revenue by Year
Tempus AI, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $1.3B).
| Year | Annual Revenue |
|---|---|
| 2025 | $1.3B |
| 2024 | $693.4M |
Tempus AI, Inc. Quarterly Revenue & Net Profit History
Tempus AI, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $367.2M | +83.0% | $-54.2M | -14.8% |
| Q3 2025 | $334.2M | +84.7% | $-80.0M | -23.9% |
| Q2 2025 | $314.6M | +89.6% | $-42.8M | -13.6% |
| Q1 2025 | $255.7M | +75.4% | $-68.0M | -26.6% |
| Q4 2024 | $200.7M | — | $-13.0M | -6.5% |
| Q3 2024 | $180.9M | +33.0% | $-75.8M | -41.9% |
| Q2 2024 | $166.0M | +25.3% | $-552.2M | -332.7% |
| Q1 2024 | $145.8M | — | $-64.7M | -44.4% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $145.8M | $166.0M | $180.9M | $200.7M | $255.7M | $314.6M | $334.2M | $367.2M |
| YoY Growth | N/A | 25.3% | 33.0% | N/A | 75.4% | 89.6% | 84.7% | 83.0% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | N/A | $864.6M | $971.7M | $926.1M | $1.54B | $1.63B | $2.28B | $2.27B |
| Liabilities | N/A | $766.4M | $918.0M | $869.8M | $1.22B | $1.32B | $1.77B | $1.78B |
| Equity | $-1.47B | $98.3M | $53.7M | $56.3M | $326.2M | $309.6M | $507.8M | $491.3M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|
| Operating CF | $-101.4M | $-97.1M | $48.7M | $-105.6M | $44.2M | $-119.8M | $-36.8M |